HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucagon-like peptide-2 (3-33)

amino acid sequence in first source

Also Known As:

GLP-2 (3-33); proglucagon (128-158)

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Fragments: 373
    - glucagon-like peptide-2 (3-33): 2
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gastrointestinal Hormones: 573
    - Proglucagon: 128
      - Glucagon-Like Peptides: 424
        Glucagon-Like Peptide 2: 107
        glucagon-like peptide-2 (3-33): 2

Experts

1.	Amato, Antonella: 1 article (12/2015)
2.	Baldassano, Sara: 1 article (12/2015)
3.	Cappello, Francesco: 1 article (12/2015)
4.	Mulè, Flavia: 1 article (12/2015)
5.	Rappa, Francesca: 1 article (12/2015)
6.	Hartmann, Bolette: 1 article (12/2013)
7.	Holst, Jens Juul: 1 article (12/2013)
8.	Kissow, Hannelouise: 1 article (12/2013)
9.	Poulsen, Steen Seier: 1 article (12/2013)

Related Diseases

1.	Glucose Metabolism Disorders 12/01/2015 - "The present study suggests that endogenous GLP-2 may act as a protective factor against the dysregulation of the glucose metabolism that occurs in HFD mice, because GLP-2 (3-33) worsens glucose metabolism disorders."
2.	Mucositis 12/01/2013 - "Mice were injected with 5-fluorouracil (5-FU) or saline to induce mucositis and were then treated with GLP-1, GLP-2, GLP-2 (3-33), exendin (9-39) or vehicle. "
3.	Glucose Intolerance 12/01/2015 - "In HFD fed mice, GLP-2 (3-33) treatment for 4 weeks (from the 6th to the 10th week of diet) did not affect fasting glycaemia, but it significantly increased the glucose intolerance, both fasting and glucose-induced insulin levels, and reduced the sensitivity to insulin leading to insulin-resistance. "
4.	Insulin Resistance 12/01/2015 - "In STD mice, the GLP-2 (3-33) treatment did not affect fasted or glucose-stimulated glycemia, insulin, insulin sensitivity, pancreas weight and beta cell mass. " 12/01/2015 - "In HFD fed mice, GLP-2 (3-33) treatment for 4 weeks (from the 6th to the 10th week of diet) did not affect fasting glycaemia, but it significantly increased the glucose intolerance, both fasting and glucose-induced insulin levels, and reduced the sensitivity to insulin leading to insulin-resistance. "

Related Drugs and Biologics

1.	Glucose (Dextrose)
2.	Glucagon-Like Peptide 1 (GLP 1)
3.	Insulin (Novolin)
4.	Fluorouracil (Carac)
5.	exendin (9-39)